Immunomodulatory Effects of NB-UVB and Steroids in Vitiligo: A Study on CXCL11 and TEMRA Biomarkers

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

December 30, 2025

Study Completion Date

September 30, 2026

Conditions

VitiligoNB-UVB

Interventions

RADIATION

NB-UVB twice weekly

Standard phototherapy without additional systemic treatment.

OTHER

NB-UVB + dexamethasone (2.5-3 mg/week)

Combination therapy to enhance immunosuppression and repigmentation.

All Listed Sponsors

lead

Assiut University

OTHER

NCT06946069 - Immunomodulatory Effects of NB-UVB and Steroids in Vitiligo: A Study on CXCL11 and TEMRA Biomarkers | Biotech Hunter | Biotech Hunter